Tempus Software Review: AI in Oncology

About Tempus Software

What is Tempus software?

Tempus is an innovative software platform founded in 2015 by Eric Lefkofsky, designed to revolutionize healthcare by leveraging big data and artificial intelligence (AI). Its primary purpose is to enhance the delivery of cancer care by providing healthcare providers with actionable insights derived from vast amounts of clinical and molecular data. The software addresses significant challenges in oncology, such as the need for personalized treatment plans and improved patient outcomes. By organizing and analyzing electronic health records, genomic sequences, and medical imaging, Tempus empowers clinicians to make informed decisions, ultimately facilitating better care for cancer patients.

Summary of Tempus Software: Usability and Features

Tempus offers a user-friendly platform that allows healthcare professionals to access and analyze comprehensive patient data in real-time. Key features include:

• Genomic Profiling: Provides insights into the genetic makeup of tumors.
• Clinical Trial Matching: Helps identify appropriate clinical trials for patients based on their unique profiles.
• EHR Integration: Seamlessly integrates with existing electronic health record systems.
• Tempus One: A powerful tool that utilizes AI to query millions of unstructured documents for research and clinical care.
• Data Collaboration: Facilitates partnerships with healthcare institutions and research organizations to broaden data utilization.

Why Choose Tempus Over Competitors? Unique Selling Points

Tempus stands out in the healthcare landscape due to several competitive advantages:

• Data-Driven Insights: Tempus extracts valuable patterns and correlations from large datasets, enhancing clinical decision-making.
• Advanced AI Capabilities: Its sophisticated algorithms identify potential biomarkers and therapeutic targets, crucial for developing novel therapies.
• Robust Partnerships: Collaborations with leading healthcare entities enhance data richness and applicability.
• Focus on Precision Medicine: Tempus actively contributes to advancing precision medicine, reshaping treatment protocols in oncology.

Ideal User Groups and Use Cases

Tempus software is best suited for a variety of professionals in the healthcare sector. Below is a table highlighting the ideal user groups and specific use cases where Tempus excels.

User Group	Use Case Description
Oncologists	Personalized treatment plans based on genomic profiling.
Clinical Researchers	Accelerating clinical trials through data integration.
Healthcare Administrators	Improving patient management with EHR integration.
Pharmaceutical Companies	Identifying biomarkers for drug development.
Hospitals and Health Systems	Enhancing patient outcomes through actionable data insights.

The comprehensive capabilities of Tempus make it a leading choice for healthcare providers looking to improve cancer care and patient outcomes through data-driven solutions.

Features

Insightful Reporting Capabilities

Tempus software offers advanced reporting capabilities designed to provide actionable insights. The platform tracks key metrics such as patient outcomes, treatment effectiveness, and operational efficiency. Businesses can leverage these reports to optimize workflows, identify improvement areas, and support data-driven decision-making.

Seamless Workflow Integrations

Tempus integrates with several key platforms, such as electronic health records (EHR) systems, laboratory information systems, and data analytics tools. These integrations streamline data exchange, enhance workflow efficiency, and enable seamless communication across platforms, ensuring that users can access and utilize data effectively.

Comprehensive Mobile Application Features

Tempus provides mobile applications for both iOS and Android platforms. These apps enable on-the-go access to critical data, allowing users to review patient information, track treatment protocols, and collaborate with team members remotely. This flexibility is especially useful for healthcare professionals who require mobility in their work.

Enhanced Security and Convenience with SSO

Tempus supports Single Sign-On (SSO) functionality, compatible with platforms such as Okta, Microsoft Azure AD, and Google Workspace. SSO enhances user convenience by enabling seamless access across multiple applications while improving security through centralized authentication processes.

Time-Saving Automation Features

The automation capabilities of Tempus simplify complex tasks like data entry, patient record management, and report generation. For example, automated data synchronization reduces manual effort, while predictive analytics tools assist in early diagnosis and treatment planning, ultimately saving time and optimizing results.

Robust Security Measures for Data Protection

Tempus employs stringent data protection measures, including encryption, secure access controls, and regular security audits. The platform complies with standards like GDPR and SOC 2, ensuring the highest level of data privacy and regulatory compliance for its users.

Versatile API Capabilities

The Tempus API enables customization and integration opportunities, allowing businesses to tailor the platform to their specific needs. Users can connect Tempus with third-party tools, develop custom applications, and enhance the functionality of existing systems.

Flexible Deployment Options

Tempus offers cloud-based deployment, ensuring accessibility, scalability, and reduced IT infrastructure costs. While cloud deployment is ideal for most users, it may not be suitable for organizations with strict on-premises data storage requirements.

Advantages and Limitations of Tempus

Pros:

• Comprehensive data insights for better decision-making.
• Seamless integrations with other platforms.
• Mobile apps for on-the-go accessibility.
• Robust security measures and compliance with standards.
• Time-saving automation features.

Cons:

• Limited deployment options as it primarily focuses on cloud-based solutions.
• May require training for users unfamiliar with advanced analytics tools.

This detailed breakdown of Tempus software’s features should provide a comprehensive understanding of its capabilities and benefits for users.

Location

Locations and Branches

Location Name	Address	City	State/Province	Country
Headquarters	Suite 510, 600 West Chicago Avenue	Chicago	Illinois	United States
New York City Office	230 Park Avenue, Suite 935/950	New York	New York	United States
Bay Area Office	450 Maple St	Redwood City	California	United States
RTP Lab	25 Alexandria Way, Suite 300	Durham	North Carolina	United States
Atlanta Lab	Northwoods Circle Business Park #4	Peachtree Corners	Georgia	United States
Washington DC Office	600 14th Street NW, Suite 506	Washington	D.C.	United States
Calgary Office	Suite 400, 119 14 Street	Calgary	Alberta	Canada
Milwaukee Office	Suite 2299, 411 E. Wisconsin Avenue	Milwaukee	Wisconsin	United States
Seattle Office	22121 17th Ave	Bothell	Washington	United States
Boston Office	Suite 16-126, 33 Arch Street	Boston	Massachusetts	United States
Lewisburg Office	434 Market Street, 2nd Floor	Lewisburg	Pennsylvania	United States
Barcelona Office	Gran Via de Carles III, 84 planta 3-4	Barcelona	Catalunya	Spain

History and Team

Year Founded

Tempus was founded in August 2015.

Number of Employees

Tempus currently has approximately 2,400 employees.

Team

The following table provides details about the founders and their roles:

Name	Position
Eric Lefkofsky	Founder
Ryan Fukushima	First Employee, Key Role in Building the Company

Tempus is dedicated to leveraging technology and AI to improve cancer care and personalize diagnostics.

Pricing

Business Model of Tempus Software

Tempus is a leading software platform designed for precision medicine and healthcare. Their business model revolves around providing AI-driven solutions that help healthcare providers, pharmaceutical companies, and researchers make data-driven decisions. Below is a detailed explanation of their pricing plans, presented in a structured table format.

Pricing Plans

Feature	Details
Service Model	SaaS (Software as a Service)
Main Offerings	AI-enabled precision medicine solutions Genomic profiling Clinical trial matching
Pricing Structure	Specific pricing details are not publicly available. Generally tailored to client needs.
Subscription Options	Customizable based on client requirements Potential for tiered pricing based on usage and services utilized
Free Trial/Demo	Information regarding free trials or demos is not explicitly mentioned on the website.
Target Clients	Healthcare providers, pharmaceutical companies, and research institutions
Contact for Pricing	Prospective clients are encouraged to contact Tempus directly for tailored pricing information.

Note: Tempus does not openly publish its pricing information, which is common for B2B SaaS companies, especially in specialized fields like healthcare and precision medicine. For exact figures and tailored plans, direct communication with the sales team is recommended.

Funding and market

Industry

Tempus operates in the healthcare and life sciences industry, specifically within the realm of precision medicine. Their software solutions leverage artificial intelligence (AI) to enhance the ability of healthcare providers and researchers to make informed decisions regarding patient care and treatment options.

Overview of the Precision Medicine Industry:

• Precision medicine tailors medical treatment to the individual characteristics, needs, and preferences of patients.
• This approach employs genetic, environmental, and lifestyle factors to design personalized treatment plans.
• Key areas include oncology, neurology, and cardiology.

AI Features and Services Provided by Tempus:

1. AI-Enabled Assistant (Tempus One): Assists healthcare providers in analyzing vast amounts of data quickly.
2. Care Pathway Intelligence (Tempus Next): Utilizes AI to guide clinical decision-making by analyzing patient data.
3. Data Analytics (Tempus Lens): Uses generative AI for research by analyzing millions of unstructured documents.
4. Algorithmic Models: Predicts treatment effectiveness and identifies clinical trials.
5. Multimodal Data Access: Enhances understanding of patient conditions and treatment outcomes.

Market

Tempus operates within the precision medicine sector, leveraging AI to analyze clinical and genomic data for personalized treatments.

Market Details:

• The global precision medicine market is projected to grow from $102.17 billion in 2024 to $470.53 billion by 2034.
• The AI in precision medicine market is expected to grow from $0.60 billion in 2023 to $3.92 billion by 2030, with a CAGR of 30.7%.
• While Tempus’ specific market share is not detailed, their innovative AI-driven approach positions them as a key player in this rapidly expanding market.

Funding

Tempus has secured significant investments over multiple funding rounds to scale its operations and enhance its AI capabilities.

Funding Details:

Funding Round	Date	Amount Raised	Type of Funding	Investors
Series A	2015	$5 million	Equity	Not specified
Series B	2016	$20 million	Equity	Not specified
Series C	2018	$70 million	Equity	Not specified
Series D	2019	$100 million	Equity	Not specified
Series E	2020	$200 million	Equity	Not specified
Series F	2021	$200 million	Equity	Not specified
Series G	2022	$275 million	Equity and Debt	Ares Management, existing investors

Summary:

• Total Investment Amount: $1.3 billion
• Total Number of Funding Rounds: 7
• The latest round raised $275 million in 2022 through a combination of equity and debt financing.

Stocks

Tempus is a publicly traded company.

• Their shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “TEM” starting June 14, 2024.
• The company recently announced the pricing of its initial public offering (IPO), which includes 11,100,000 shares of its Class A common stock at a public offering price of $37.00 per share.
• The gross proceeds from this offering are expected to be approximately $410.7 million, subject to closing conditions.

This comprehensive analysis covers Tempus’ industry, market, funding, and stock details, providing a detailed insight into their business and financial structure.

Latest news

The Current and Inevitable Expansion of AI in Oncology

Source: Targeted Oncology

AI is revolutionizing oncology by processing vast amounts of data at unprecedented speeds, empowering healthcare providers with tools like Tempus One. Tempus One, a generative AI-enabled clinical assistant, received FDA approval in mid-2023. It offers seamless access to patient data and is integrated into platforms like Lens Data Analytics. This collaboration allows users to analyze Tempus’ de-identified, multimodal data library for insights, patient cohort building, and population analysis.

Dr. Sandip Patel, an oncologist at UC San Diego Health, emphasized the significance of AI tools like Tempus One in precision oncology, enabling providers to access comprehensive research data easily. Other AI tools, such as DermaSensor, a wireless device for detecting skin cancers, are also making waves in healthcare.

Professor Christopher E. Mason from Weill Cornell Medicine explained how AI enhances DNA-sequencing and tumor analysis, enabling breakthroughs in spatial transcriptomics and imaging analysis. While AI provides numerous benefits, challenges such as data interpretation bias, overconfidence in algorithms, cost, and HIPAA compliance remain.

Tempus’ advancements have positioned it as a leader in AI-driven oncology, significantly impacting patient care and research.

Tempus Announces Collaboration with IFLI for Targeted Therapies

Source: Tempus Investor Relations

Tempus has announced a collaboration with the International Follicular Lymphoma Initiative (IFLI) aimed at developing targeted therapies for follicular lymphoma. This partnership will leverage Tempus’ AI capabilities to enhance precision medicine approaches. The collaboration underscores Tempus’ commitment to tackling rare cancers and improving individualized care.

These initiatives highlight Tempus’ role in advancing healthcare through AI and strategic collaborations, making it a standout player in the field of precision oncology.

Search Trends

Analysis of Tempus’ Search Volume Trends

Search Volume Data for Tempus

The table below showcases the search volumes and related metrics for various keywords associated with Tempus:

Keyword	Search Volume	Competition	Competition Index	Cost-per-Click (CPC)	Low Top of Page Bid	High Top of Page Bid
Tempus company	320	Low	2	$6.23	$0.01	$6.00
Tempus AI	22,200	Low	2	$2.34	$0.42	$5.12
Tempus precision medicine	30	Low	13	$8.67	$5.45	$7.79
clinical data Tempus	No data available	No data	No data	No data	No data	No data

Factors Influencing Tempus’ Popularity Trends

• Product Launches:
  • Clinical launch of the Immune Profile Score (IPS) algorithmic test for oncology.
  • Launch of MRD testing portfolio for early cancer recurrence detection (xM MRD, NeXT Personal Dx).
  • Introduction of the xM MRD assay for colorectal cancer research.
  • Launch of the xR standalone RNA sequencing test for solid tumors.
  • Expansion of genomic profiling offerings with the xF+ liquid biopsy panel.
• Partnerships:
  • Collaboration with Stemline Therapeutics to implement the AI-enabled Tempus Next platform for metastatic breast cancer care.
• Innovative Platforms:
  • Launch of the Edge platform utilizing AI and data for identifying therapeutic options earlier in treatment.
• Technological Innovations:
  • Announcement of the xM Monitor assay for monitoring immunotherapy responses using circulating tumor DNA.
• Market Expansion:
  • Expansion into oncology diagnostics, addressing a $70 billion market opportunity.

These developments highlight Tempus’ active role in advancing precision medicine, leveraging AI and data-driven solutions, and expanding their market presence, which contributes to their search volume trends.

Review

Customers:

Tempus is a leading AI health technology company that collaborates with academic medical centers, community health systems, and pharmaceutical companies to enhance patient care through genomic testing, clinical data aggregation, and AI-driven diagnostics. The platform is utilized in oncology, neuropsychology, radiology, and cardiology, significantly impacting treatment decisions and drug discovery efforts.

Alternatives:

Below is a table comparing alternative software options to Tempus, detailing their features, pricing, and target audiences:

Alternative Software	Features	Pricing	Target Audience
FreshBooks	User-friendly accounting tool for small businesses and freelancers with customizable invoicing, time tracking, automation features.	$5.7 per month	Small businesses and freelancers
QuickBooks Time	Time tracking solution for workforce management, real-time insights, mobile app access.	$15 per month	Businesses of all sizes
Zoho Invoice	Invoicing software for small businesses, easy invoice creation, expense tracking.	Free or contact vendor for more options	Small businesses
Zoho Projects	Project management tool with task management, time tracking, collaboration features.	$280 per month	Teams and organizations
Workday HCM	Cloud-based HR management focusing on payroll and workforce analytics.	Contact vendor for pricing	Larger organizations
Sage Timeslips	Billing software for professional services, supports various billing arrangements.	$55 per month	Small businesses and legal practices
Toggl Track	Time-tracking tool with one-click tracking and detailed reporting.	$9 per month	Freelancers and small teams
Harvest	Time tracking and invoicing software, integrates with project management tools.	$10.80 per month	Freelancers and businesses

Comparing FlowHunt with Tempus

FlowHunt and Tempus both leverage AI to automate complex workflows and process diverse data sources. While Tempus focuses on healthcare-specific tasks like patient journey visualization and clinical trial matching, FlowHunt enables users to achieve similar automation and data insights across industries. By utilizing FlowHunt’s Visual Builder, users can create custom workflows and deploy AI agents for repetitive tasks, integrating multiple knowledge sources like PDFs and websites. FlowHunt empowers users with flexibility, making AI-driven solutions accessible beyond healthcare.